Epigral Q2 FY27: revenue up 27.0% to ₹746 Cr, net profit up 27.1% to ₹65 Cr
Results · Finvezto · 2 Nov 2026 · Epigral (EPIGRAL)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 746 | +5.8% | +27.0% |
| Operating profit | 136 | -24.1% | +2.8% |
| Net profit | 65 | -34.7% | +27.1% |
| Operating margin | 18.2% | -7.2 pp | -4.3 pp |
| Net margin | 8.7% | -5.4 pp | +0.0 pp |
Key points
- Epigral Limited reported Q2 FY27 revenue of Rs 752 crore, up 28% year-on-year from Rs 589 crore, with EBITDA of Rs 136 crore against Rs 132 crore and net profit rising 26% to Rs 64 crore. NSE filing
- Growth was driven by improved realisations and 6% volume growth, with the Derivatives and Specialty business contributing 57% of revenue. NSE filing
- Revenue for Q2 FY27 increased 28% year-on-year to INR 752 crores driven by volume growth and improved product realizations, while PAT grew 26% to INR 64 crores. Earnings call
- EBITDA rose 3% year-on-year to INR 136 crores with margins contracting to 18% due to elevated raw material costs, freight rates, and volatile West Asia geopolitical conditions. Earnings call
What to watch
- Management on commissioning timeline: We expect to commission both plants within a quarter time.
- Management on h2 fy27 outlook: Consequently, we maintained positive outlook for H2 FY27.
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 17.2%, 22.9%, 25.4%, 18.2%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 39, 81, 100, 65.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.